Platelet activation suppresses HIV-1 infection of T cells

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Solomon Tsegaye, Theodros ^a   Gnirß, Kerstin ^a,b   Rahe Meyer, Niels ^a   Kiene, Miriam ^a   Krämer Kühl, Annika ^a,b   Behrens, Georg ^a   Münch, Jan ^c   Pöhlmann, Stefan ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b GERMAN PRIMATE CENTER   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

CXCL4; Entry; HIV 1; Platelet

Indexed keywords

CHEMOKINE; CXCL4 CHEMOKINE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL GRANULE; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGRANULATION; EMBRYO; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; THROMBOCYTE ACTIVATION; VIRAL TROPISM; VIRUS ENTRY; VIRUS STRAIN; VIRUS TRANSMISSION;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HIV-1; HUMANS; PLATELET ACTIVATION; PLATELET FACTOR 4; VIRUS INTERNALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84876801146     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-48     Document Type: Article

References (49)

1. AIDS epidemic update 2009. http://www.unaids.org.
2. Lusso P. HIV and the chemokine system: 10 years later. EMBO J 2006, 25:447-456. 10.1038/sj.emboj.7600947, 1383531, 16437164.
3. Ugolini S, Mondor I, Sattentau QJ. HIV-1 attachment: another look. Trends Microbiol 1999, 7:144-149. 10.1016/S0966-842X(99)01474-2, 10217828.
4. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597. 10.1016/S0092-8674(00)80694-7, 10721995.
5. van Montfort T, Nabatov AA, Geijtenbeek TB, Pollakis G, Paxton WA. Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes. J Immunol 2007, 178:3177-3185.
6. Beck Z, Brown BK, Wieczorek L, Peachman KK, Matyas GR, Polonis VR, Rao M, Alving CR. Human erythrocytes selectively bind and enrich infectious HIV-1 virions. PLoS One 2009, 4:e8297. 10.1371/journal.pone.0008297, 2788743, 20011536.
7. Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science 2010, 328:562-564. 10.1126/science.328.5978.562, 20430990.
8. McMorran BJ, Marshall VM, de Graaf C, Drysdale KE, Shabbar M, Smyth GK, Corbin JE, Alexander WS, Foote SJ. Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science 2009, 323:797-800. 10.1126/science.1166296, 19197068.
9. Passos AM, Treitinger A, Spada C. An overview of the mechanisms of HIV-related thrombocytopenia. Acta Haematol 2010, 124:13-18. 10.1159/000313782, 20606410.
10. Rieg G, Yeaman M, Lail AE, Donfield SM, Gomperts ED, Daar ES. Platelet count is associated with plasma HIV type 1 RNA and disease progression. AIDS Res Hum Retroviruses 2007, 23:1257-1261. 10.1089/aid.2006.0311, 17961113.
11. Lee TH, Stromberg RR, Henrard D, Busch MP. Effect of platelet-associated virus on assays of HIV-1 in plasma. Science 1993, 262:1585-1586.
12. Lee TH, Stromberg RR, Heitman JW, Sawyer L, Hanson CV, Busch MP. Distribution of HIV type 1 (HIV-1) in blood components: detection and significance of high levels of HIV-1 associated with platelets. Transfusion 1998, 38:580-588. 10.1046/j.1537-2995.1998.38698326338.x, 9661692.
13. Youssefian T, Drouin A, Masse JM, Guichard J, Cramer EM. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 2002, 99:4021-4029. 10.1182/blood-2001-12-0191, 12010803.
14. Boukour S, Masse JM, Benit L, Dubart-Kupperschmitt A, Cramer EM. Lentivirus degradation and DC-SIGN expression by human plateletes and megakaryocytes. J Thromb and Haemost 2006, 4:426-435.
15. Chaipan C, Soilleux EJ, Simpson P, Hofmann H, Gramberg T, Marzi A, Geier M, Stewart EA, Eisemann J, Steinkasserer A. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J Virol 2006, 80:8951-8960. 10.1128/JVI.00136-06, 1563896, 16940507.
16. Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009, 23:177-189. 10.1016/j.blre.2009.04.001, 2720568, 19450911.
17. Auerbach DJ, Lin Y, Miao H, Cimbro R, Difiore MJ, Gianolini ME, Furci L, Biswas P, Fauci AS, Lusso P. Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor. Proc Natl Acad Sci U S A 2012, 109:9569-74. 10.1073/pnas.1207314109, 3386099, 22645343.
18. Holme PA, Muller F, Solum NO, Brosstad F, Froland SS, Aukrust P. Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection. FASEB J 1998, 12:79-89.
19. Mayne E, Funderburg NT, Sieg SF, Asaad R, Kalinowska M, Rodriguez B, Schmaier AH, Stevens W, Lederman MM. Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression. J Acquir Immune Defic Syndr 2012, 59:340-346. 10.1097/QAI.0b013e3182439355, 3299881, 22156911.
20. Stone D, Liu Y, Shayakhmetov D, Li ZY, Ni S, Lieber A. Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver. J Virol 2007, 81:4866-4871. 10.1128/JVI.02819-06, 1900148, 17301138.
21. Gear AR, Camerini D. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 2003, 10:335-350.
22. Slungaard A. Platelet factor 4: a chemokine enigma. Int J Biochem Cell Biol 2005, 37:1162-1167. 10.1016/j.biocel.2004.12.003, 15778080.
23. Nguyen DG, Hildreth JE. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur J Immunol 2003, 33:483-493. 10.1002/immu.200310024, 12645947.
24. Pollicita M, Schols D, Aquaro S, Peumans WJ, Van Damme EJ, Perno CF, Balzarini J. Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes. Virology 2008, 370:382-391. 10.1016/j.virol.2007.08.033, 17928023.
25. Gramberg T, Hofmann H, Moller P, Lalor PF, Marzi A, Geier M, Krumbiegel M, Winkler T, Kirchhoff F, Adams DH. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology 2005, 340:224-36. 10.1016/j.virol.2005.06.026, 16051304.
26. Gramberg T, Soilleux E, Fisch T, Lalor PF, Hofmann H, Wheeldon S, Cotterill A, Wegele A, Winkler T, Adams DH. Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral ligands: differential pH dependence, internalization and virion binding. Virology 2008, 373:189-201. 10.1016/j.virol.2007.11.001, 18083206.
27. Means RE, Greenough T, Desrosiers RC. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus. J Virol 1997, 71:7895-7902. 192146, 9311879.
28. Zander DM, Klinger M. The blood platelets contribution to innate host defense - what they have learned from their big brothers. Biotechnol J 2009, 4:914-926. 10.1002/biot.200800362, 19507148.
29. Bruisten S, van Gemen B, Koppelman M, Rasch M, van Strijp D, Schukkink R, Beyer R, Weigel H, Lens P, Huisman H. Detection of HIV-1 distribution in different blood fractions by two nucleic acid amplification assays. AIDS Res Hum Retroviruses 1993, 9:259-265. 10.1089/aid.1993.9.259, 8471317.
30. Sabino EC, Gaburo N, Leite JP, Viecili M, Rosenfeld LG. Platelets may affect detection and quantitation of HIV RNA in plasma samples with low viral loads. J Acquir Immune Defic Syndr 2004, 37:1432-1433. 10.1097/00126334-200411010-00013, 15483474.
31. Chaipan C, Steffen I, Tsegaye TS, Bertram S, Glowacka I, Kato Y, Schmokel J, Münch J, Simmons G, Gerardy-Schahn R. Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2. Retrovirology 2010, 7:47. 10.1186/1742-4690-7-47, 2885308, 20482880.
32. Massberg S, Konrad I, Schurzinger K, Lorenz M, Schneider S, Zohlnhoefer D, Hoppe K, Schiemann M, Kennerknecht E, Sauer S. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 2006, 203:1221-1233. 10.1084/jem.20051772, 2121205, 16618794.
33. Corrales-Medina VF, Simkins J, Chirinos JA, Serpa JA, Horstman LL, Jy W, Ahn YS. Increased levels of platelet microparticles in HIV-infected patients with good response to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2010, 54:217-218. 10.1097/QAI.0b013e3181c8f4c9, 20505474.
34. O'Brien M, Montenont E, Hu L, Nardi MA, Valdes V, Merolla M, Gettenberg G, Cavanagh K, Aberg JA, Bhardwaj N. Aspirin attenuates platelet activation and immune activation in HIV-infected subjects on antiretroviral therapy: a pilot study. J Acquir Immune Defic Syndr 2013, [Epub ahead of print].
35. Decrion AZ, Dichamp I, Varin A, Herbein G. HIV and inflammation. Curr HIV Res 2005, 3:243-259. 10.2174/1570162054368057, 16022656.
36. Jayachandran M, Brunn GJ, Karnicki K, Miller RS, Owen WG, Miller VM. In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk. J Appl Physiol 2007, 102:429-433.
37. von HP, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007, 100:27-40. 10.1161/01.RES.0000252802.25497.b7, 17204662.
38. Schwartzkopff F, Grimm TA, Lankford CS, Fields K, Wang J, Brandt E, Clouse KA. Platelet factor 4 (CXCL4) facilitates human macrophage infection with HIV-1 and potentiates virus replication. Innate Immun 2009, 15:368-379. 10.1177/1753425909106171, 19773294.
39. Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, Ni H, Lazarus AH, Freedman J, Semple JW. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 2006, 107:637-641. 10.1182/blood-2005-06-2202, 16179373.
40. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 1998, 72:2855-2864. 109730, 9525605.
41. Schmitz G, Rothe G, Ruf A, Barlage S, Tschope D, Clemetson KJ, Goodall AH, Michelson AD, Nurden AT, Shankey TV. European working group on clinical cell analysis: consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 1998, 79:885-896.
42. Pöhlmann S, Leslie GJ, Edwards TG, Macfarlan T, Reeves JD, Hiebenthal-Millow K, Kirchhoff F, Baribaud F, Doms RW. DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions. J Virol 2001, 75:10523-10526. 10.1128/JVI.75.21.10523-10526.2001, 114631, 11581425.
43. Hiebenthal-Millow K, Pöhlmann S, Münch J, Kirchhoff F. Differential regulation of human immunodeficiency virus type 2 and simian immunodeficiency virus promoter activity. Virology 2004, 324:501-509. 10.1016/j.virol.2004.04.007, 15207635.
44. Pöhlmann S, Stolte N, Münch J, Ten HP, Heeney JL, Stahl-Hennig C, Kirchhoff F. Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo. J Infect Dis 1999, 180:1494-1502. 10.1086/315097, 10515808.
45. Connor RI, Chen BK, Choe S, Landau NR. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995, 206:935-944. 10.1006/viro.1995.1016, 7531918.
46. Pierson TC, Zhou Y, Kieffer TL, Ruff CT, Buck C, Siliciano RF. Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J Virol 2002, 76:8518-8531. 10.1128/JVI.76.17.8518-8513.2002, 136977, 12163571.
47. Simmons G, Reeves JD, Grogan CC, Vandenberghe LH, Baribaud F, Whitbeck JC, Burke E, Buchmeier MJ, Soilleux EJ, Riley JL. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003, 305:115-123. 10.1006/viro.2002.1730, 12504546.
48. Papkalla A, Münch J, Otto C, Kirchhoff F. Nef enhances human immunodeficiency virus type 1 infectivity and replication independently of viral coreceptor tropism. J Virol 2002, 76:8455-8459. 10.1128/JVI.76.16.8455-8459.2002, 155138, 12134048.
49. Schindler M, Wurfl S, Benaroch P, Greenough TC, Daniels R, Easterbrook P, Brenner M, Münch J, Kirchhoff F. Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles. J Virol 2003, 77:10548-10556. 10.1128/JVI.77.19.10548-10556.2003, 228419, 12970439.